Welcome to our dedicated page for Home Bancshares SEC filings (Ticker: HOMB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Home BancShares, Inc. filings document the public-company reporting of a bank holding company and its Centennial Bank subsidiary. Form 8-K reports furnish quarterly earnings releases, Regulation FD disclosures, material-event updates, and completed acquisition activity, including merger documentation for bank-holding-company and subsidiary-bank transactions.
Proxy and shareholder-meeting filings cover board elections, advisory compensation votes, director appointments, executive compensation, equity award disclosure, and other governance matters. The company’s filings also address capital-structure items, voting results, operating and financial results, and disclosure controls relevant to a NYSE-listed banking organization.
Home BancShares, Inc. director and Director of Investor Relations Donna Townsell reported routine equity movements in company stock. On January 16, 2026, she received a grant of 33,000 shares of restricted common stock at no cost, bringing her restricted stock holdings to 36,000 shares. On December 18, 2025, she reported two transactions coded "G" for 500 common shares each, one held indirectly as custodian for her daughter and one affecting her direct holdings, both at a reported price of $0, indicating non-sale transfers.
Following these updates, she reports direct and indirect common stock positions along with performance-based restricted stock and stock options, including a 50,000-share performance stock option and other options over 20,000 and 10,000 shares, all exercisable in scheduled installments as described in the footnotes.
Home Bancshares director Alex R. Lieblong reported receiving a grant of 3,000 shares of Common Stock – Restricted Stock on January 16, 2026 at a stated price of $0 per share. Following this award, he directly holds 6,000 restricted shares and 563,645 shares of common stock.
The filing notes that the restricted stock granted on January 16, 2026 will vest in three equal 33 1/3% installments over three years, beginning on the first anniversary of the award date. Prior grants from January 2024 and January 2025 follow the same vesting pattern, and 3,000 restricted shares have vested since the last filing.
Home BancShares director Robert H. Adcock Jr. reported new equity activity in the company’s stock. On January 16, 2026, he received 3,000 shares of restricted common stock at a price of $0, bringing his directly held restricted stock to 6,000 shares. According to the filing, restricted stock granted on January 16, 2026 will vest in equal 33 1/3% installments over three years beginning on the first anniversary of the award date.
The filing also shows a transaction with code G on the same date involving 3,461 shares of common stock at a price of $0, held indirectly by the Carol Adcock Trust, which now holds 209,871 shares for his benefit. In addition, the report lists other indirect holdings, including 1,146,970 shares held by the Robert H. Adcock Trust and 79,426 shares held by an IRA, along with a note that 3,000 restricted shares vested since the prior filing.
Home BancShares director James G. Hinkle reported an equity award and updated share holdings. On January 16, 2026, he received 3,000 shares of Home BancShares common stock as restricted stock at a price of $0 per share, increasing his restricted stock balance to 6,000 shares. The filing notes that restricted stock granted on January 16, 2026 will vest in 33 1/3% installments over three years beginning on the first anniversary of the award date. Following the reported transactions, Hinkle directly holds 39,625 shares of common stock and indirectly holds 487,127 shares through a revocable trust.
Home BancShares Inc. director Jim Rankin reported an equity compensation grant and updated shareholdings. On January 16, 2026, he received 3,000 shares of restricted common stock at a price of $0 per share, increasing his restricted stock holdings to 6,000 shares. The filing notes that restricted stock grants made on January 19, 2024, January 17, 2025, and January 16, 2026 each vest in three equal 33 1/3% installments over three years starting on the first anniversary of the award date.
The document also shows that Rankin directly held 224,617.0017 shares of Home BancShares common stock after the reported transactions. A footnote explains that 3,000 shares of restricted stock vested since the last filing, moving from restricted status into freely owned common shares.
Home BancShares director Karen Garrett reported an equity award and updated holdings. On January 16, 2026, she received 3,000 shares of restricted common stock at a price of $0 per share, increasing her restricted stock holdings to 6,000 shares. Following this report, she also holds 20,500 shares of common stock directly and 4,500 shares of common stock indirectly through the HCJ 401(k) Plan.
The filing explains that restricted stock granted on January 19, 2024, January 17, 2025, and January 16, 2026 will each vest in 33 1/3% installments over three years, beginning on the first anniversary of the respective award dates. It also notes that 3,000 shares of restricted stock vested since the prior filing, reflecting ongoing delivery of previously granted equity compensation.
Home BancShares director Milburn Adams reported a new equity award and updated holdings. On January 16, 2026, Adams received 3,000 shares of restricted common stock at a price of $0, bringing his restricted stock holdings to 6,000 shares held directly.
The filing also shows direct ownership of 147,006 shares of common stock following the reported transactions. Footnotes explain that restricted stock granted on January 19, 2024, January 17, 2025, and January 16, 2026 will each vest in 33 1/3% installments over three years, beginning on the first anniversary of each award date, and that 3,000 restricted shares have vested since the prior report.
Home BancShares director Mike Beebe reported an equity award and updated holdings. On January 16, 2026, he was granted 3,000 shares of restricted common stock at a grant price of $0 per share, increasing his directly held restricted stock to 6,000 shares. He also directly holds 22,000 shares of common stock.
Restricted stock granted on January 19, 2024, January 17, 2025, and January 16, 2026 will each vest in equal 33 1/3% installments over three years, beginning on the first anniversary of the respective award dates. Since the prior filing, 3,000 restricted shares have vested, reflecting ongoing realization of earlier equity awards as they meet time-based vesting conditions.
Home BancShares Chief Financial Officer and director Brian Davis reported an equity compensation update. On January 16, 2026, he was granted 3,000 shares of restricted common stock at a price of $0 per share, increasing his restricted stock holdings to 6,000 shares after the transaction. He also reports 3,334 performance-based restricted shares and 98,525 shares of common stock held directly, plus 7,128 shares in an IRA and 2,888.3782 shares in a 401(k). In addition, Davis holds 20,000 performance stock options with an exercise price of $23.32 per share, which vest in equal annual installments based on a previously met performance goal. Several prior restricted and performance awards continue to vest over multi-year schedules.
Home BancShares director Thomas J. Longe reported new equity compensation and updated share holdings. On January 16, 2026, he received 3,000 shares of restricted common stock at a price of $0, bringing his total restricted stock ownership to 6,000 shares.
The filing shows additional direct ownership of 24,000 shares of common stock and indirect ownership of 9,500 shares of common stock held by an IRA. Footnotes state that restricted stock awards granted in 2024, 2025 and 2026 each vest in three equal annual installments beginning one year after the grant date, and that 3,000 restricted shares vested since the prior filing.
Longe also holds a stock option on 10,000 shares of common stock with an exercise price of $19.12, expiring on April 17, 2029. The option becomes exercisable in five equal annual installments, with the first installment having become exercisable on April 18, 2020.